KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹25 Cr | ₹-2.39 Cr | ₹-1.91 Cr | ₹-1.24 Cr | ₹-0.90 Cr |
What is the latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-2.39 Cr |
| Mar2023 | ₹-1.91 Cr |
| Mar2022 | ₹-1.24 Cr |
| Mar2021 | ₹-0.90 Cr |
How is Total Non-Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-2.39 Cr | Negative | |
| Mar2023 | ₹-1.91 Cr | Negative | |
| Mar2022 | ₹-1.24 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | - | |
Compare Total Non-Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹650.1 Cr | 13.4% | 5.8% | 15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 13.4% |
5.8% |
15.7% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses